Open AccessL1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma
Author(s) -
Jussuf T. Kaifi,
Ulrich Zinnkann,
Emre F. Yekebas,
Paulus G. Schurr,
Uta Reichelt,
Robin Wachowiak,
Henning C. Fiegel,
Susann Petri,
Melitta Schachner,
Jakob R. Izbicki
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i1.94
Subject(s) - neuroendocrine tumors , pancreas , immunohistochemistry , pathology , neuroendocrine differentiation , medicine , carcinoma , cancer , prostate cancer
To determine the expression of L1 in pancreatic neuroendocrine tumor and to correlate it with WHO classification of this tumor.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom